Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126877242 | 12687724 | 2 | F | 20160718 | 20160907 | 20160825 | 20160913 | EXP | FR-PFIZER INC-2016389810 | PFIZER | 45.00 | YR | F | Y | 0.00000 | 20160913 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126877242 | 12687724 | 1 | PS | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, 1 TO 3 TABLETS DAILY, AS NEEDED | U | 18276 | .5 | MG | TABLET | ||||||
126877242 | 12687724 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 9 MG, SINGLE | U | 18276 | 9 | MG | TABLET | ||||||
126877242 | 12687724 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 2 G, SINGLE | U | 18989 | 2 | G | |||||||
126877242 | 12687724 | 4 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 10 MG, DAILY | U | 0 | 10 | MG | |||||||
126877242 | 12687724 | 5 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 210 MG, SINGLE | U | 0 | 210 | MG | |||||||
126877242 | 12687724 | 6 | SS | SOLIAN | AMISULPRIDE | 1 | Oral | 600 MG, DAILY | U | 0 | 600 | MG | TABLET | ||||||
126877242 | 12687724 | 7 | SS | SOLIAN | AMISULPRIDE | 1 | Oral | 1800 MG, SINGLE | U | 0 | 1800 | MG | TABLET | ||||||
126877242 | 12687724 | 8 | SS | METEOSPASMYL | ALVERINE CITRATEDIMETHICONE | 1 | Oral | 3 DF, SINGLE | U | 0 | 3 | DF | CAPSULE, SOFT | ||||||
126877242 | 12687724 | 9 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 50 MG, SINGLE | U | 0 | 50 | MG | |||||||
126877242 | 12687724 | 10 | SS | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 210 MG, SINGLE | U | 0 | 210 | MG | |||||||
126877242 | 12687724 | 11 | SS | CLORAZEPATE DIPOTASSIUM. | CLORAZEPATE DIPOTASSIUM | 1 | Oral | 40 MG, SINGLE | U | 0 | 40 | MG | |||||||
126877242 | 12687724 | 12 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 100 MG, SINGLE | U | 0 | 100 | MG | |||||||
126877242 | 12687724 | 13 | C | TERCIAN /00759301/ | CYAMEMAZINE | 1 | 25 MG, 1X/DAY (AT BEDTIME) | 0 | 25 | MG | QD | ||||||||
126877242 | 12687724 | 14 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126877242 | 12687724 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126877242 | 12687724 | Blood pressure systolic increased | |
126877242 | 12687724 | Coma | |
126877242 | 12687724 | Disturbance in attention | |
126877242 | 12687724 | Electrocardiogram QT prolonged | |
126877242 | 12687724 | Extensor plantar response | |
126877242 | 12687724 | Intentional overdose | |
126877242 | 12687724 | Miosis | |
126877242 | 12687724 | Sinus tachycardia | |
126877242 | 12687724 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126877242 | 12687724 | 2 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 3 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 5 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 7 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 8 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 9 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 10 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 11 | 20160718 | 20160718 | 0 | |
126877242 | 12687724 | 12 | 20160718 | 20160718 | 0 |